McKesson Corporation

NYSE:MCK

Medical - Distribution

Healthcare
$1,084.43 -3.71%

-$28.96 today

Market cap
$125.21B
Beta
0.32
P/E (TTM)
19.3
EPS (TTM)
$39.00
Dividend yield
0.44%
52W Low $637.00High $999.00

Volume 0.67M

Average 1.03M

MCK Inventory

Cash effect of the change in inventory; building inventory consumes cash.

McKesson CorporationNYSE: MCK

Inventory · Q1 FY2027 · quarter ended Jun 2026

Inventory growth accelerates

Q1 FY2027 inventory of $2.07B (cash outflow) rose 5.2% year over year, ahead of the -689.6% change in trailing-twelve-month inventory. Over 3 fiscal years it compounded at -4.9% a year.

Context

  • Inventory amounted to 0.3% of revenue in FY2026, down 0.4 pp from a year earlier.
  • Inventory grew in size in 2 of the last 3 fiscal years.
  • FY2026 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +5.2% holds above the trailing-twelve-month pace of -689.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$2.07B-168.8% QoQ
Last fiscal yearMar 2026
-$1.08B-52.3% YoY
LTMJun 2026
-$1.19B-689.6% YoY
Inventory past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.2%——
1 year-52.3%——
3-year CAGR-4.9%——
5-year CAGR——
10-year CAGR——

Inventory history

USD · from the cash flow

Latest · FY2026
(1.08B) USD
Year-over-year change
+52.3%

Inventory vs competitors

How MCK compares with its peers on the latest reported figures

  • MCK's LTM Jun 2026 inventory of $1.19B is the 2nd largest of the 4 companies compared; the peer median is $923M.
  • Its year-over-year change of -689.6% is the lowest of 4, against a peer median of -16.8%.
  • Inventory amounts to 0.3% of revenue for MCK, versus a peer median of 0.4%.
MCK Competitors Peer median
Inventory for MCK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CORCencora, Inc.LTM Jun 2026$1.33B -16.8%+24.0%0.4%
MCKMcKesson CorporationLTM Jun 2026$1.19B -689.6%-4.9%0.3%
CAHCardinal Health, Inc.LTM Sep 2026$923M -50.7%+5.8%0.4%
ACHAccendra Health, Inc.LTM Mar 2026$276.89M +204.3%—10.2%
Peer median (excluding MCK) $923M-16.8%+14.9%0.4%

Competitors are the stored peer set for MCK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Net Income1.29B3.72B3.16B3.48B4.76B
Depreciation & Amortization760M608M635M636M729M
Deferred Income Tax34M(20M)(603M)(110M)230M
Stock-Based Compensation161M162M000
Change in Working Capital82M384M(64M)1.16B162M
Accounts Receivables(1.84B)(1.08B)(2.95B)(3.94B)(2B)
Inventory(1.17B)(1.26B)(1.29B)(2.27B)(1.08B)
Accounts Payables2.8B3.79B004.32B
Other Working Capital292M(1.06B)4.18B7.36B(1.07B)
Other Non-Cash Items2.11B303M1.19B923M272M
Operating Cash Flow4.43B5.16B4.31B6.09B6.16B
Capital Expenditures(535M)(558M)(687M)(859M)(745M)
Acquisitions (Net)572M210M(225M)155M(2.59B)
Purchases of Investments(446M)0000
Sales of Investments446M866M000
Other Investing Activities(126M)(1.06B)(416M)(351M)(101M)
Investing Cash Flow(89M)(542M)(1.07B)(733M)(3.43B)
Debt Repayment(1.15B)(277M)56M(21M)783M
Common Stock Issued220M163M116M101M89M
Common Stock Repurchased(3.52B)(3.64B)(3.03B)(3.15B)(4.75B)
Dividends Paid(277M)(292M)(314M)(345M)(381M)
Other Financing Activities(1.38B)(324M)(175M)(554M)(372M)
Financing Cash Flow(6.32B)(4.37B)(3.34B)(3.97B)(4.63B)
Effect of Forex Changes(485M)495M6M(16M)(73M)
Net Change in Cash(2.46B)744M(94M)1.37B(1.98B)
Free Cash Flow3.9B4.6B3.63B5.23B5.41B

McKesson Corporation

NYSE:MCK

Intrinsic Alpha fair value

Locked

Current Price

$1,084.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.